Fred Alger Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-22,508
Closed -$6.08M 529
2021
Q4
$6.08M Buy
22,508
+22,296
+10,517% +$5.52M 0.02% 283
2021
Q3
$51K Hold
212
﹤0.01% 467
2021
Q2
$50K Buy
+212
New +$48.3K ﹤0.01% 470
2020
Q3
Sell
-120
Closed -$17K 502
2020
Q2
$17K Sell
120
-330
-73% -$45.7K ﹤0.01% 462
2020
Q1
$49K Buy
450
+22
+5% +$3.17K ﹤0.01% 420
2019
Q4
$62K Buy
428
+330
+337% +$47.6K ﹤0.01% 430
2019
Q3
$14K Buy
+98
New +$14.3K ﹤0.01% 465
2019
Q1
Sell
-178
Closed -$19K 541
2018
Q4
$19K Hold
178
﹤0.01% 453
2018
Q3
$27K Buy
+178
New +$27.1K ﹤0.01% 452

Other funds holding LH

Fred Alger Management's LH Position: Q1 2022 in Review

Fred Alger Management sold out of Labcorp (LH) in Q1 2022, closing a stake of 22,508 shares — an estimated $6.08M sold.

Fred Alger Management first reported a position in LH in Q3 2018 and held it in 9 quarters. The position peaked at $6.08M in Q4 2021. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • Fred Alger Management reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
  • Fred Alger Management sold 22,508 Labcorp shares in Q1 2022, an estimated $6.08M.
  • Fred Alger Management first reported a position in Labcorp in Q3 2018 and held it in 9 quarters.
  • Fred Alger Management's Labcorp position peaked at $6.08M in Q4 2021.
  • 1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Fred Alger Management's 13F filing for Q1 2022, filed 16 May 2022.